US EditionWe’ve seen patients on transplant lists taken off of them after starting Winrevair, says Merck CEO
Summary by brandmarketingready.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
We’ve seen patients on transplant lists taken off of them after starting Winrevair, says Merck CEO
Share Mad Money with Jim Cramer Merck Chairman and CEO Robert Davis joins ‘Mad Money’ host Jim Cramer at the JPMorgan Healthcare Conference to talk recent acquisitions, growth in its vaccine segment, opportunities in China and more. 01:39 Tue, Jan 14 20257:49 PM EST Jim Cramer
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
